Sage Therapeutics
SAGE
$11.90
Share price
-3.57%
Change (1 day)
-77.39%
Change (1 year)
Categories
P/S ratio for Sage Therapeutics (SAGE)
P/S ratio as of May 2024 (TTM): 7.90
According to Sage Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.89747. At the end of 2023 the company had a P/S ratio of 15.0.
P/S ratio history for Sage Therapeutics from 2014 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 15.0 | -94.9% |
| 2022 | 295 | -25.7% |
| 2021 | 397 | 8678.4% |
| 2020 | 4.53 | -99.17% |
| 2019 | 545 | 995.97% |
| 2018 | 49.8 | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Regulus Therapeutics RGLS | N/A | N/A | 🇺🇸 USA |
 Intercept Pharmaceuticals
ICPT | 2.50 | -68.33% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | 7.31 | -7.47% | 🇮🇪 Ireland |
 Eagle Pharmaceuticals
EGRX | 0.2294 | -97.09% | 🇺🇸 USA |